TY - JOUR
T1 - Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion
AU - Georgiadou, Eleni
AU - Chabosseau, Pauline
AU - Akalestou, Elina
AU - Tomas, Alejandra
AU - Lopez-Noriega, Livia
AU - Leclerc, Isabelle
AU - Rutter, Guy A.
AU - Muralidharan, Charanya
AU - Martinez, Michelle
AU - Linnemann, Amelia K.
AU - Wern, Fiona Yong Su
AU - Ali, Yusuf
AU - Stylianides, Theodoros
AU - Wretlind, Asger
AU - Legido-Quigley, Cristina
AU - Jones, Ben
AU - Xu, Yanwen
AU - Gu, Guoqiang
AU - Alsabeeh, Nour
AU - Cruciani-Guglielmacci, Célline
AU - Magnan, Christophe
AU - Ibberson, Mark
AU - Soleimanpour, Scott A.
AU - Rodriguez, Tristan A.
N1 - Funding Information:
The authors thank Stephen M. Rothery, from the Facility for Imaging by Light Microscopy (FILM) at Imperial College London, for support with confocal and widefield microscopy image recording and analysis. The authors thank Professor Julia Gorelik and Sasha Judina (Imperial College) for providing the Epac1-camps sensor, and Aida Di Gregorio from the National Heart and Lung Institute (Imperial College) for genotyping the mice.
Funding Information:
Acknowledgments. The authors thank Stephen M. Rothery, from the Facility for Imaging by Light Microscopy (FILM) at Imperial College London, for support with confocal and widefield microscopy image recording and analysis. The authors thank Professor Julia Gorelik and Sasha Judina (Imperial College) for providing the Epac1-camps sensor, and Aida Di Gregorio from the National Heart and Lung Institute (Imperial College) for genotyping the mice. Funding. G.A.R. was supported by a Wellcome Trust Senior Investigator Award (098424AIA) and Wellcome Trust Investigator Award (212625/Z/18/Z), Medical Research Council Programme grants (MR/R022259/1, MR/J0003042/ 1, MR/L020149/1), an Experimental Challenge Grant (DIVA, MR/L02036X/1), a Medical Research Council grant (MR/N00275X/1), and Diabetes UK grants (BDA/11/0004210, BDA/15/0005275, BDA16/0005485). I.L. was supported by a Diabetes UKD project grant (16/0005485). This project has received funding from the European Commission Innovative Medicines Initiative 2 Joint Undertaking, under grant agreement no. 115881 (RHAPSODY). This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme. This work is supported by the Swiss State Secretariat for Education, Research and Innovation (SERI), under contract no. 16.0097. A.T. was supported by Medical Research Council project grant MR/R010676/ 1. Intravital imaging was performed using resources and/or funding provided by National Institutes of Health grants R03 DK115990 (to A.K.L.), Human Islet Research Network UC4 DK104162 (to A.K.L., RRID:SCR_014393). BJ acknowledges support from the Academy of Medical Sciences, Society for Endocrinology, The British Society for Neuroendocrinology, the European Federation for the Study of Diabetes, an Engineering and Physical Sciences Research Council capital award, and the Medical Research Council (MR/R010676/1). S.A.S. was supported by the JDRF (CDA-2016-189, SRA-2018-539, COE-2019-861), the National Institutes of Health (R01 DK108921, U01 DK127747), and the U.S. Department of Veterans Affairs (I01 BX004444). Duality of Interest. This Joint Undertaking receives support from the European Federation of Pharmaceutical Industries and Associations. G.A.R. has received grant funding and consultancy fees from Les Laboratoires Servier and Sun Pharmaceuticals. No other potential conflicts of interest relevant to this article were reported. Author Contributions. E.G. performed experiments and analyzed data. E.G. supported the completion of confocal and widefield microscopy and analysis. E.G. contributed to designing the study and writing the manuscript C.M., M.M., and A.K.L. were responsible for the in vivo intravital Ca21 imaging in mice presented in the bioRxiv paper [41]. P.C. contributed to the analysis and manipulation of the in vivo intravital Ca21 measurements as well as the preparation and imaging of total internal reflection fluorescence samples. E.A. and L.L.N. performed the oral gavage in live animals. A.T. performed the electron microscopy sample processing and data analysis. F.Y.S.W. and Y.A. generated and performed Monte Carlo-based signal binar-ization. T.S. contributed to the generation of the MATLAB script used for connectivity analysis. A.W. and C.L.-Q. contributed to the metabolomics analysis. B.J. assisted with the cAMP assays. Y.X. and G.G. performed studies with the Pdx1CreER mice. N.A. assisted with Seahorse experiment protocols. C.C.-G., C.M., and M.I. were responsible for the RNA sequencing data analysis. I.L. and T.A.R. were responsible for the maintenance of mouse colonies and final approval of the version to be published. S.A.S. performed studies with Cle-c16a mice. T.A.R. was involved in the design of the floxed Mfn alleles. G.A.R. designed the study and wrote the manuscript with input and final approval of the version to be published from all authors. G.A.R. is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Publisher Copyright:
© 2022, American Diabetes Association Inc.. All rights reserved.
PY - 2022/7
Y1 - 2022/7
N2 - Mitochondrial glucose metabolism is essential for stimulated insulin release from pancreatic β-cells. Whether mitofusin gene expression, and hence, mitochondrial network integrity, is important for glucose or incretin signaling has not previously been explored. Here, we generated mice with β-cell-selective, adult-restricted deletion knock-out (dKO) of the mitofusin genes Mfn1 and Mfn2 (βMfn1/2 dKO). βMfn1/2-dKO mice displayed elevated fed and fasted glycemia and a more than fivefold decrease in plasma insulin. Mitochondrial length, glucose-induced polarization, ATP synthesis, and cytosolic and mitochondrial Ca2+ increases were all reduced in dKO islets. In contrast, oral glucose tolerance was more modestly affected in βMfn1/2-dKO mice, and glucagon-like peptide 1 or glucose-dependent insulinotropic peptide receptor agonists largely corrected defective glucose-stimulated insulin secretion through enhanced EPAC-dependent signaling. Correspondingly, cAMP increases in the cytosol, as measured with an Epac-camps-based sensor, were exaggerated in dKO mice. Mitochondrial fusion and fission cycles are thus essential in the β-cell to maintain normal glucose, but not incretin, sensing. These findings broaden our understanding of the roles of mitofusins in β-cells, the potential contributions of altered mitochondrial dynamics to diabetes development, and the impact of incretins on this process.
AB - Mitochondrial glucose metabolism is essential for stimulated insulin release from pancreatic β-cells. Whether mitofusin gene expression, and hence, mitochondrial network integrity, is important for glucose or incretin signaling has not previously been explored. Here, we generated mice with β-cell-selective, adult-restricted deletion knock-out (dKO) of the mitofusin genes Mfn1 and Mfn2 (βMfn1/2 dKO). βMfn1/2-dKO mice displayed elevated fed and fasted glycemia and a more than fivefold decrease in plasma insulin. Mitochondrial length, glucose-induced polarization, ATP synthesis, and cytosolic and mitochondrial Ca2+ increases were all reduced in dKO islets. In contrast, oral glucose tolerance was more modestly affected in βMfn1/2-dKO mice, and glucagon-like peptide 1 or glucose-dependent insulinotropic peptide receptor agonists largely corrected defective glucose-stimulated insulin secretion through enhanced EPAC-dependent signaling. Correspondingly, cAMP increases in the cytosol, as measured with an Epac-camps-based sensor, were exaggerated in dKO mice. Mitochondrial fusion and fission cycles are thus essential in the β-cell to maintain normal glucose, but not incretin, sensing. These findings broaden our understanding of the roles of mitofusins in β-cells, the potential contributions of altered mitochondrial dynamics to diabetes development, and the impact of incretins on this process.
UR - http://www.scopus.com/inward/record.url?scp=85133103048&partnerID=8YFLogxK
U2 - 10.2337/db21-0800
DO - 10.2337/db21-0800
M3 - Journal article
C2 - 35472764
AN - SCOPUS:85133103048
SN - 0012-1797
VL - 71
SP - 1472
EP - 1489
JO - Diabetes
JF - Diabetes
IS - 7
ER -